These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 18884684)

  • 1. The relationship between heparin dosage and clotting time.
    JAQUES LB; RICKER AG
    Blood; 1948 Oct; 3(10):1197-1212. PubMed ID: 18884684
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mechanism of prolonged hypocoagulation appearing after intratracheal administration of heparin].
    Efimov VS; Rumiantseva AG; Golovleva OA; Rozkin MIa
    Biull Eksp Biol Med; 1992 May; 113(5):509-12. PubMed ID: 1421273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Letter: Heparin dosage and clotting time.
    Gurewich V; Lipinski B
    Ann Intern Med; 1974 Oct; 81(4):567-8. PubMed ID: 4414251
    [No Abstract]   [Full Text] [Related]  

  • 4. Heparinization during percutaneous cardiac catheterization in children.
    Netz H; Madu B; Röhner G
    Pediatr Cardiol; 1987; 8(3):167-8. PubMed ID: 3432104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin dosing and monitoring for cardiopulmonary bypass. A comparison of techniques with measurement of subclinical plasma coagulation.
    Gravlee GP; Haddon WS; Rothberger HK; Mills SA; Rogers AT; Bean VE; Buss DH; Prough DS; Cordell AR
    J Thorac Cardiovasc Surg; 1990 Mar; 99(3):518-27. PubMed ID: 2308370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of sodium heparin and antithrombin III concentration on activated partial thromboplastin time in the dog.
    Hellebrekers LJ; Slappendel RJ; van den Brom WE
    Am J Vet Res; 1985 Jul; 46(7):1460-2. PubMed ID: 4026027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated clotting time for control of anticoagulation during surgery.
    Lefemine AA; Lewis M
    Am Surg; 1985 May; 51(5):274-8. PubMed ID: 3994170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring heparin therapy with the activated partial thromboplastin time.
    Stuart RK; Michel A
    Can Med Assoc J; 1971 Mar; 104(5):385-8. PubMed ID: 5557913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An improved plasma recalcified clotting test and its modification as a simple rapid heparin retarded clotting test.
    EASTHAM RD
    J Clin Pathol; 1962 Jan; 15(1):86-7. PubMed ID: 13888970
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of the activated clotting time to control heparin andprotamine dosage in open-heart surgery.
    Arkin CF; Shahsavari M; Copeland BE; Kim A
    J Thorac Cardiovasc Surg; 1978 May; 75(5):790-2. PubMed ID: 642581
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of aureomycin on heparin concentration and clotting time of human blood.
    WAISBREN BA; GLICK D
    Proc Soc Exp Biol Med; 1950 Nov; 75(2):476-7. PubMed ID: 14808297
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of aureomycin on heparin concentration and clotting time of human blood.
    WAISBREN BA; GLICK D
    J Lab Clin Med; 1950 Dec; 36(6):1001. PubMed ID: 14795098
    [No Abstract]   [Full Text] [Related]  

  • 13. Blood coagulation in leucemia and polycythemia; value of the heparin clotting time and clot retraction rate.
    ROSENTHAL RL
    J Lab Clin Med; 1949 Oct; 34(10):1321-35. PubMed ID: 18143596
    [No Abstract]   [Full Text] [Related]  

  • 14. Low-dose heparin in routine hemodialysis monitored by activated partial thromboplastin time.
    Shapiro WB; Faubert PF; Porush JG; Chou SY
    Artif Organs; 1979 Feb; 3(1):73-7. PubMed ID: 435127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodialysis without heparin infusion using Cordis Dow 3500 hollow fiber.
    Raja R; Kramer M; Rosenbaum JL; Bolisay C; Krug M
    Proc Clin Dial Transplant Forum; 1980; 10():39-42. PubMed ID: 7346852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Adjusted Calculation Model Allows for Reduced Protamine Doses without Increasing Blood Loss in Cardiac Surgery.
    Kjellberg G; Sartipy U; van der Linden J; Nissborg E; Lindvall G
    Thorac Cardiovasc Surg; 2016 Sep; 64(6):487-93. PubMed ID: 26270199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical evaluation of heparin concentration and activated clotting time monitoring (HEPCON HMS) system].
    Sakurada T; Kikuchi Y; Koushima R; Nakashima S; Hachiro Y; Kagaya H
    Nihon Kyobu Geka Gakkai Zasshi; 1997 Jun; 45(6):836-40. PubMed ID: 9217380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Individual dosage schedule of heparin therapy in chronic hemodialysis by analytic studies of blood coagulation].
    Gläser V; Anstadt M
    Z Urol Nephrol; 1990 Mar; 83(3):133-40. PubMed ID: 2356667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in blood coagulation following coronary thrombosis measured by the heparin retarded clotting test (Waugh and Ruddick test).
    OGURA JH; FETTER NR
    Proc Annu Meet Cent Soc Clin Res U S; 1945; 18():47. PubMed ID: 21021618
    [No Abstract]   [Full Text] [Related]  

  • 20. Significance of clotting tests augmented by heparin.
    WEINER M; JIMINEZ M
    Am J Clin Pathol; 1956 Mar; 26(3):243-6. PubMed ID: 13302169
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.